Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) ...

Gerard Cassidy, RBC Capital Markets large cap bank analyst, joins 'Squawk Box' to discuss Donald Trump's victory in the 2024 ...

RBC Capital analyst Brad Erickson maintained a Hold rating on Vivid Seats (SEAT – Research Report) on November 4 and set a price target ...

RBC Capital analyst Michael Siperco maintained a Buy rating on New Gold (NGD – Research Report) on November 4 and set a price target of ...

Fidelity National Information Services beats Q3 estimates, and raises full-year outlook Analysts maintain rating.

Interest rate-sensitive areas of the market and cryptocurrencies are among some of the areas expected to see big moves based ...

Lineage Inc.’s first quarterly report after raising $5.1 billion in the year’s biggest US initial public offering will be a ...

Oil edged higher as the tight US presidential election looms over global markets while a tropical storm threatens production ...

CIBC analyst Sid Mokhtari prefers the TSX to the S&P 500 and offered ten domestic stock ideas to play the theme. His matrix ...

Wall Street expects the company to report $1.3 billion in revenue and an adjusted diluted loss per share of $1.73 for the ...

West Texas Intermediate traded near $72 a barrel after rising 0.7% on Tuesday, with Brent crude closing below $76.

If Trump were to win, curbs on Russian oil exports could be eased, while there might also be tighter sanctions on Iranian ...